Portable skin dressing shows promise for rare blistering disease
NCT ID NCT05944250
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study tested a portable device called Spincare that sprays a nanofiber dressing onto wounds in people with recessive dystrophic epidermolysis bullosa (RDEB), a rare genetic condition causing fragile, blistering skin. Six participants with at least six chronic or recurrent wounds were enrolled. The study compared healing of treated wounds versus untreated ones over four months, also tracking side effects like pain or redness. The goal was to see if this easy-to-apply dressing is safe and helps wounds close.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Spincare matrix (a portable device that applies a nanofiber dressing to wounds)
What this could lead to
If it works, this could offer a new, easy-to-use dressing that helps RDEB wounds heal faster and with less pain.
What could go wrong
This is a very small pilot study with only 6 participants, so results may not apply to everyone. The dressing is temporary and not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Discovery Hall Stanford University
Redwood City, California, 94063, United States